Loading
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
Latest quote
$0.9277
−$0.0023 · -0.25%
Canopy Growth Corporation (CGC), alongside its affiliated businesses, specializes in the cultivation, marketing, and retail of both cannabis and hemp-derived products. These offerings are designed for both recreational consumption and therapeutic uses, with its primary commercial reach extending across Canada, the United States, and Germany. The company structures its operations into two main divisions: Global Cannabis and a diverse portfolio of Other Consumer Products. Its extensive product range features dried cannabis flower, various extracts and concentrates, infused beverages, edible gummies, and vape cartridges. Canopy Growth distributes these items under numerous well-known brands, such as Tweed, 7ACRES, Martha Stewart CBD, and Spectrum Therapeutics, among others. Originally founded as Tweed Marijuana Inc., the enterprise adopted its current name, Canopy Growth Corporation, in September 2015. Established in 2009, the firm maintains its corporate headquarters in Smiths Falls, Canada.
Previous close
$0.9277
−$0.0023 · -0.25%
Regular session · ET · Market data may be delayed.
Canopy Growth Corporation (CGC), alongside its affiliated businesses, specializes in the cultivation, marketing, and retail of both cannabis and hemp-derived products. These offerings are designed for both recreational consumption and therapeutic uses, with its primary commercial reach extending across Canada, the United States, and Germany. The company structures its operations into two main divisions: Global Cannabis and a diverse portfolio of Other Consumer Products. Its extensive product range features dried cannabis flower, various extracts and concentrates, infused beverages, edible gummies, and vape cartridges. Canopy Growth distributes these items under numerous well-known brands, such as Tweed, 7ACRES, Martha Stewart CBD, and Spectrum Therapeutics, among others. Originally founded as Tweed Marijuana Inc., the enterprise adopted its current name, Canopy Growth Corporation, in September 2015. Established in 2009, the firm maintains its corporate headquarters in Smiths Falls, Canada.
Day range
Current $0.9277
52-week range
Current $0.9277
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
68
Undervalued
Sentiment
51
Mixed
Risk
71
High Risk
Momentum
27
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Canopy Growth Corporation (CGC), alongside its affiliated businesses, specializes in the cultivation, marketing, and retail of both cannabis and hemp-derived products. These offerings are designed for both recreational consumption and therapeutic uses, with its primary commercial reach extending across Canada, the United States, and Germany. The company structures its operations into two main divisions: Global Cannabis and a diverse portfolio of Other Consumer Products. Its extensive product range features dried cannabis flower, various extracts and concentrates, infused beverages, edible gummies, and vape cartridges. Canopy Growth distributes these items under numerous well-known brands, such as Tweed, 7ACRES, Martha Stewart CBD, and Spectrum Therapeutics, among others. Originally founded as Tweed Marijuana Inc., the enterprise adopted its current name, Canopy Growth Corporation, in September 2015. Established in 2009, the firm maintains its corporate headquarters in Smiths Falls, Canada.
Day range
Current $0.9277
52-week range
Current $0.9277
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (CAD) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 284.6M CAD | 269M CAD | 297.15M CAD | 333.25M CAD | 475.7M CAD |
| Cost of goods sold | 214.93M CAD | 189.48M CAD | 216.26M CAD | 396.78M CAD | 663.11M CAD |
| Gross profit | 69.67M CAD | 79.51M CAD | 80.88M CAD | −63.53M CAD | −187.41M CAD |
| Research and development | — | — | 4.61M CAD | 21.72M CAD | 32.26M CAD |
| Selling, general, and administrative | 122.93M CAD | 121.71M CAD | 180.59M CAD | 297.98M CAD | 361.1M CAD |
| Operating expenses | 142.78M CAD | 196.65M CAD | 309.6M CAD | 2.57B CAD | 831.39M CAD |
| Interest income | 10M CAD | 8.82M CAD | 16.24M CAD | 24.28M CAD | 6.6M CAD |
| Interest expense | 38.19M CAD | 74.57M CAD | 105.35M CAD | 126.16M CAD | 103.94M CAD |
| Depreciation and amortization | 36.47M CAD | 43.12M CAD | 53.18M CAD | 80.03M CAD | 110.94M CAD |
| Operating income | −73.11M CAD | −117.14M CAD | −228.71M CAD | −2.63B CAD | −1.02B CAD |
| Net income | −262.91M CAD | −598.12M CAD | −657.27M CAD | −3.28B CAD | −310.04M CAD |
Company facts updated Sep 12, 2026.
Reported history and fiscal-year consensus
Reported history and fiscal-year consensus
Third-party consensus; not a GoAI recommendation.
Average target
$14.47
1459.77% upside| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Dec 20, 2023 | 1:10 | — | — |
Effective Dec 20, 2023
1:10
Funds reporting this stock among their holdings, ordered by reported position size.
Amplify Alternative Harvest ETFMJ7.99M7.43%108.73M USD1.12%$25.44-1.00%
AdvisorShares Pure Cannabis ETFYOLO354.89K1.03%34.61M USD0.91%$2.92-4.03%
State Street SPDR S&P Emerging Markets Small Cap ETFEWX143.86K0.02%684.6M USD0.65%$72.61+0.30%
Avantis Emerging Markets ex-China Equity ETFAVXC50.97K0.01%468.84M USD0.33%$84.0059+1.45%
Avantis Emerging Markets Value ETFAVES37.62K—1.55B USD0.36%$66.29+1.16%
Avantis Responsible Emerging Markets Equity ETFAVSE19.62K0.01%229.94M USD0.33%$80.075+1.41%
Avantis Emerging Markets Equity ETFAVEM17K—28.6B USD0.33%$95.35+1.29%
Avantis Emerging Markets Small Cap Equity ETFAVEE11.93K0.01%141.01M USD0.42%$69.08+0.73%Amplify Alternative Harvest ETFMJAdvisorShares Pure Cannabis ETFYOLOState Street SPDR S&P Emerging Markets Small Cap ETFEWXAvantis Emerging Markets ex-China Equity ETFAVXCAvantis Emerging Markets Value ETFAVESAvantis Responsible Emerging Markets Equity ETFAVSEAvantis Emerging Markets Equity ETFAVEMAvantis Emerging Markets Small Cap Equity ETFAVEEAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
